AstraZeneca Gets CDSCO Panel nod to study Anti-cancer Drug Datopotamab Deruxtecan and Durvalumab Dr. Divya Colin23 Feb 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee SEC functional under the Central Drug Standard Control...
Roche anti-cancer drug Atezolizumab gets CDSCO panel nod for Metastatic Triple Negative Breast Cancer Rahul Verma15 July 2022 4:53 PM ISTBased on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug Standard...
CDSCO panel nod to Roche anti cancer drug Atezolizumab for metastatic triple negative breast cancer Dr. Divya Colin14 July 2022 6:00 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical giant Roche, the Subject Expert Committee (SEC) functional under Central Drug...
Gilead Sciences, Merck collaborate to evaluate Trodelvy in combo with Keytruda Ruchika Sharma31 Oct 2021 9:30 AM ISTFoster City: Gilead Sciences, Inc. has recently announced the company has entered into a clinical trial collaboration and supply agreement with Merck...
